Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 1, 2025 | Reprieve Cardiovascular | $61.0M Series B | David Neustaedter | Arboretum Ventures, Lightstone Ventures, Hanson S. Gifford, Genesis Capital, Anita Watkins, Sante Ventures |